Antibiotice Iasi posts 11 pct higher year-on-year net profit in H1 2019

Medical drugs manufacturer Antibiotice Iasi (ATB) reported a net profit of RON 22.3 million in the first six months of 2019, an 11 percent increase compared to the same period of 2018, with sales revenues of RON 172.3 million, 9 percent higher than the corresponding period of the previous year, according to the report published by the company on the Bucharest Stock Exchange website. At the end of June 2019, spending on raw materials and consumables had ...

Developed by Codecraftsman